Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in PALI — Palisade Bio, Inc.

CIK 1166588 NEW YORK, NY
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$47,129
-$284,077 QoQ
Shares Held
22,550
-88.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 124 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. PALI ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in PALI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,129 22,550
2026-03-31 $331,206 189,261